Abstract
Astaxanthin is a red carotenoid pigment which exerts multiple biological activities. However, little is known about the effects of astaxanthin on matrix metalloproteinases (MMPs) in OA. The present study investigated the effects of astaxanthin on MMPs in human chondrocytes. Human chondrocytes were pretreated with astaxanthin at 1, 10 or 50 μM, then, cells were stimulated with IL-1β (10 ng/ml) for 24 h. MMP-1, MMP-3 and MMP-13 were observed. We found that astaxanthin reduced the expression of MMP-1, MMP-3 and MMP-13 as well as the phosphorylation of two mitogen-activated protein kinases (MAPK) (p38 and ERK1/2) in IL-1β-stimulated chondrocytes. Astaxanthin also blocked the IκB-α degradation. These results suggest that astaxanthin may be beneficial in the treatment of OA. © 2014 Elsevier B.V.
Author supplied keywords
Cite
CITATION STYLE
Chen, W. P., Xiong, Y., Shi, Y. X., Hu, P. F., Bao, J. P., & Wu, L. D. (2014). Astaxanthin reduces matrix metalloproteinase expression in human chondrocytes. International Immunopharmacology, 19(1), 174–177. https://doi.org/10.1016/j.intimp.2013.12.007
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.